Head and Neck
The session will review current standard treatment guidelines for the most common head and neck cancers in lecture based review of seminal studies. Understanding the basis for understanding normal tissue tolerance to optimize function preservation and quality of life will be discussed. Ongoing trials of new treatment approaches will be highlighted.
The meeting is designed to meet the interests of practicing radiation oncologists, radiation oncology residents, medical and clinical physicists, nurses and all other health professionals involved in the field of radiation oncology.
Upon completion of this activity, participants should be able to do the following:
- Describe how to minimize toxicity with improved understanding of OAR and tumor contouring.
- Discuss the need for incorporating other treatment modalities with RT to optimize oncologic outcomes.
- Outline current treatment paradigms and future clinical research directions.
Kenneth Shung Hu, MD, FASTRO, is employed by and has no financial relationships with a commercial interest.
All relevant relationships have been mitigated.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.
ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.
- 1.50 AMA PRA Category 1 Credit™The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.50 Certificate of AttendanceThis activity was designated for 1.50 AMA PRA Category 1 Credit™.